Market Tracker

05/23 12:37pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

189.17
BATS BZX Real-Time Price
As of 12:37pm ET
 +2.08 / +1.11%
Today’s Change
107.65
Today|||52-Week Range
196.56
+38.15%
Year-to-Date

Today’s Trading

Previous close187.09
Today’s open187.66
Day’s range187.08 - 190.43
Volume5,995
Average volume (3 months)338,193
Market cap$3.9B
Data as of 12:37pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+56.81%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+29.48%
P/E ratio88.3
Price/Sales22.79
Price/Book9.59

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...+0.40+1.21%
GWPHGW Pharmaceuticals P...+5.21+3.43%
MDCOMedicines Co0.000.00%
CBPOChina Biologic Produ...+0.07+0.09%
Data as of 12:37pm ET, 05/23/2018

Financials

Next reporting dateAugust 6, 2018
EPS forecast (this quarter)$0.96
Annual revenue (last year)$141.1M
Annual profit (last year)$12.6M
Net profit margin8.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts